Profile picture

Miss Bo Goovaerts

University of Antwerp, Antwerp (Belgium)
Follow
Logo ESC

Contributor content

A newly developed small-molecule ErbB4 agonist reduces reactive cardiac fibrosis and adverse ventricular remodelling after myocardial infarction in a sex-specific manner.
Presentation
A newly developed small-molecule ErbB4 agonist reduces reactive cardiac fibrosis and adverse ventricular remodelling after myocardial infarction in a sex-specific manner.
Read more
A novel ERBB4 agonist attenuates cardiac remodelling after myocardial infarction in a sex-specific manner
Presentation
A novel ERBB4 agonist attenuates cardiac remodelling after myocardial infarction in a sex-specific manner
Read more

ESC 365 is supported by

novartis Explore sponsored resources